2016-11-15T17:09:41-06:00 2015-12-31 BKD LLP 10001 REUNION PLACE SUITE 400 SAN ANTONIO TX 782164137 990 2015-01-01 454765222 BIOBRIDGE GLOBAL % BENJAMIN LOPEZ BIOB 2107579505 6211 IH 10 WEST SAN ANTONIO TX 78201 DONNA RESPONDEK EXECUTIVE VP/CFO 2107579505 2016-11-15 true Jeanette Verrelli P00742631 2103419400 2016-11-15 2015 2017-02-10 21:41:12Z MARTIN LANDON 6211 IH 10 WEST SAN ANTONIO TX 78201 21041681 false X WWW.BIOBRIDGEGLOBAL.ORG X 2012 TX BIOBRIDGE GLOBAL (BBG) IS ORGANIZED FOR THE EXCLUSIVE PURPOSE OF SUPPORTING, AS THE SOLE MEMBER, SOUTH TEXAS BLOOD & TISSUE CENTER (STBTC), QUALTEX LABORATORIES (SEE SCH. O) 13 10 185 13 0 0 3824 0 18583132 19701762 989614 1193793 12723 24042 19589293 20919597 0 0 0 0 12222485 12844441 0 0 0 6386320 6881362 18608805 19725803 980488 1193794 54308482 69607450 6086875 21793253 48221607 47814197 X BIOBRIDGE GLOBAL (BBG) IS ORGANIZED FOR THE EXCLUSIVE PURPOSE OF SUPPORTING, AS THE SOLE MEMBER, SOUTH TEXAS BLOOD & TISSUE CENTER (STBTC), QUALTEX LABORATORIES (QUALTEX), GENCURE, AND THE BLOOD & TISSUE CENTER FOUNDATION (THE FOUNDATION) BY PROVIDING SUPPORT AND ADMINISTRATIVE FUNCTIONS THAT PROMOTE AND SUPPORT THE CHARITABLE MISSION AND PURPOSES OF STBTC, QUALTEX, GENCURE, AND THE FOUNDATION (EACH OF WHICH IS A 501(C)(3) ORGANIZATION). false false 19725803 19726698 BIOBRIDGE GLOBAL IS ORGANIZED FOR THE EXCLUSIVE PURPOSE OF SUPPORTING, AS THE SOLE MEMBER, SOUTH TEXAS BLOOD & TISSUE CENTER (STBTC), QUALTEX LABORATORIES (QUALTEX), GENCURE AND THE BLOOD & TISSUE CENTER FOUNDATION (THE FOUNDATION) BY PROVIDING SUPPORT AND ADMINISTRATIVE FUNCTIONS THAT PROMOTE AND SUPPORT THE CHARITABLE MISSION AND PURPOSES OF STBTC, QUALTEX, GENCURE, AND THE FOUNDATION. 19725803 true false false false false false false false false false true false false false true false false true false false false false false false false false false false false true false false false false false false false false false false false false false true true true false false true 56 0 true 185 true false false false false false false false false false false X 13 10 false false true false false false false true true true false true true true true true true true true true false X BENJAMIN LOPEZ 2107579505 6211 IH 10 WEST SAN ANTONIO TX 78201 X LINDA KAY MYERS EX-OFFICIO DIRECTOR / CEO 49.0 1.0 X X 527901 0 33737 MICHAEL KREAGER CHAIR/ GENERAL COUNSEL 1.0 0.0 X X 0 0 0 MICHAEL D BELDON VICE CHAIR 1.0 0.0 X X 0 0 0 JOHN FEIK SECRETARY 1.0 0.0 X X 0 0 0 DARRYL G WALDRON PHD TREASURER 1.0 0.0 X X 0 0 0 KENNETH KEN GINDY DIRECTOR 1.0 0.0 X 0 0 0 CHARLES JAY LERNER MD FSHEA DIRECTOR 1.0 0.0 X 0 0 0 BLANCA C MOLINA MD DIRECTOR 1.0 0.0 X 0 0 0 EMILY SKILLMAN DIRECTOR 1.0 0.0 X 0 0 0 GARY V WOODS DIRECTOR 1.0 0.0 X 0 0 0 STEVEN R BROOK DIRECTOR 1.0 0.0 X 0 0 0 KENNETH P TREVETT JD DIRECTOR 1.0 0.0 X 0 0 0 DENNIS STAHL DIRECTOR 1.0 0.0 X 0 0 0 RACHEL-LOUISE BEDDARD MEDICAL DIRECTOR 50.0 0.0 X 268352 0 51739 JENNIFER DAWN DUVEN ASSOCIATE MEDICAL DIRECTOR 50.0 0.0 X 190188 0 7961 SAMANTHA GOMEZ NGAMSUNTIKUL ASSOCIATE MEDICAL DIRECTOR 50.0 0.0 X 187994 0 16641 DONNA MARIE RESPONDEK EXECUTIVE VP/ CFO 50.0 0.0 X 256357 0 35129 MARK GAGER VP OF STRATEGY / TECHNOLOGY 50.0 0.0 X 235685 0 42689 CARMEN DAVILA VP CORP. COMM. (THRU 07/15) 50.0 0.0 X 142496 0 16475 PATRICIA CAPPELLI VP REGULATORY/MEDICAL AFFAIRS 50.0 0.0 X 170655 0 22463 REBECCA ANN MADERE VP HUMAN RESOURCES 50.0 0.0 X 181183 0 27976 MICHAEL SHEARN CONTRACT RISK ANALYST 50.0 0.0 X 162236 0 7048 SEAN THOMPSON VP BUS. DEV./INT. COO- GENCURE 50.0 0.0 X 209623 0 34260 SANDRA FAYE MUNOZ EXECUTIVE VP HUMAN RESOURCES 0.0 0.0 X 114219 0 1246 NORMAN D KALMIN CEO EMERITUS & MEDICAL DIR. 0.0 0.0 X 146160 0 8546 2793049 0 305910 22 true true false CDW COMPUTER CENTERS INC 75 REMITTANCE DR SUITE 1515 CHICAGO IL 606751515 SOFTWARE/EQU. MAINT. 272663 C S JANITORIAL SERVICES INC 6706 BOURGEOIS ROAD HOUSTON TX 77066 JANITORIAL 278171 STRATEGY MANAGEMENT INSTITUTE LLC 433 SUSAN CONTANT DR VIRGINIA BEACH VA 23451 PROFESSIONAL SVS 208350 CLARKSTON-POTOMAC GROUP 2655 MERIDIAN PARKWAY DURHAM NC 27713 SAP CONSULTING SVS 205353 LEADINGEDGE PERSONNEL PO BOX 2675 SAN ANTONIO TX 78299 TEMP SVS 190929 7 X 0 SUPPORT AND ADMINISTRATIVE FEES 551112 19701762 19701762 19701762 1193793 1193793 0 0 121190 122084 -894 0 -894 -894 0 0 0 0 OTHER REVENUE 551112 24936 24936 24936 24936 24936 20919597 19726698 1192899 0 0 0 0 2082162 2082162 0 8525324 8448458 76866 370030 366463 3567 1181194 1175117 6077 685731 679916 5815 0 28639 28639 51820 51820 0 0 0 829129 829129 88247 88247 359249 359249 1531960 1531960 0 2337630 2337630 162773 162773 0 84360 84360 0 0 875879 875879 43109 43109 SERVICES PURCHASED BY RELATED -92325 -92325 EQUIPMENT MAINTENANCE & REPAIR 216360 216360 MEMBERSHIP DUES & SUBSCRIPTION 146186 146186 EDUCATION & TRAINING 109029 109029 109317 109317 19725803 19725803 0 0 X 2842858 759404 9327564 475507 0 0 0 317176 0 0 0 0 56863 88414 0 0 762727 879900 19642157 12254049 6042702 7388108 34925768 59348941 0 0 0 0 0 0 350000 350000 54308482 69607450 2513683 2036432 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3573192 19756821 6086875 21793253 X 48221607 47814197 0 0 0 0 48221607 47814197 54308482 69607450 1193794 -1601204 X false true X true false X X 4 SOUTH TEXAS BLOOD & TISSUE CENTER 237379332 9 true 0 12729320 QUALTEX LABORATORIES 208429619 9 true 0 11709180 THE BLOOD & TISSUE CENTER FOUNDATION 431970952 9 true 0 267082 GENCURE 462216869 9 true 0 4383352 4 0 29088934 true false false false false false false false false false false false false false false true Schedule A, Part 1 Biobridge Global is reimbursed for all the cost incurred in support of each supported organization. Schedule A, Part I, Line 11g, Column III - TYPE OF ORGANIZATION PER THE FORM 990 INSTRUCTIONS AND THE REQUIREMENTS FOR ELECTRONIC FILING, QUALTEX LABORATORIES AND THE BLOOD & TISSUE CENTER FOUNDATION HAVE BEEN DESIGNATED AS TYPE 9 ORGANIZATIONS. THOUGH THEY EACH MEET THE REQUIREMENTS OF A TYPE 9 ORGANIZATION, THEY ARE BEST CLASSIFIED AS TYPE 10 AND TYPE 11A, RESPECTIVELY. THESE ARE THEIR RESPECTIVE CLASSIFICATIONS PER THEIR IRS EXEMPTION LETTERS. 0 1162204 577107 585097 16364547 9981609 6382938 2115406 1695333 420073 7388108 0 INTERCOMPANY PAYABLE 19756821 19756821 19440477 -1601204 -1601204 21041681 -122084 -122084 20919597 19847887 122084 122084 19725803 19725803 SCHEDULE D, PART X, LINE 2 - ASC 740 FOOTNOTE MANAGEMENT HAS EVALUATED THEIR INCOME TAX POSITIONS UNDER THE GUIDANCE INCLUDED IN ASC 740. BASED ON THEIR REVIEW, MANAGEMENT HAS NOT IDENTIFIED ANY MATERIAL UNCERTAIN TAX POSITIONS TO BE RECORDED OR DISCLOSED IN THE FINANCIAL STATEMENTS. SCHEDULE D, PART XI, LINE 4B - AMOUNTS INCLUDED ON FORM 990 NOT ON LINE 1 RENTAL EXPENSES -$122,084 SCHEDULE D, PART XII, LINE 2D - AMOUNTS INCLUDED ON LINE 1 NOT ON FORM 990 RENTAL EXPENSES $122,084 X false true X X X X X X true false false false false true true false false LINDA KAY MYERS EX-OFFICIO DIRECTOR / CEO 366549 0 150987 0 10365 0 20295 0 13442 0 561638 0 RACHEL-LOUISE BEDDARD MEDICAL DIRECTOR 236095 0 29412 0 2845 0 20295 0 31444 0 320091 0 JENNIFER DAWN DUVEN ASSOCIATE MEDICAL DIRECTOR 178791 0 9500 0 1897 0 0 0 7961 0 198149 0 SAMANTHA GOMEZ NGAMSUNTIKUL ASSOCIATE MEDICAL DIRECTOR 185982 0 0 0 2012 0 2142 0 14499 0 204635 0 DONNA MARIE RESPONDEK EXECUTIVE VP/ CFO 215211 0 36689 0 4457 0 19700 0 15429 0 291486 0 SANDRA FAYE MUNOZ EXECUTIVE VP HUMAN RESOURCES 0 0 0 0 114219 0 0 0 1246 0 115465 0 NORMAN D KALMIN CEO EMERITUS & MEDICAL DIR. 15485 0 90000 0 40675 0 3370 0 5176 0 154706 0 CARMEN DAVILA VP CORP. COMM. (THRU 07/15) 59606 0 18240 0 64650 0 5977 0 10498 0 158971 0 PATRICIA CAPPELLI VP REGULATORY/MEDICAL AFFAIRS 138181 0 28956 0 3518 0 11908 0 10555 0 193118 0 REBECCA ANN MADERE VP HUMAN RESOURCES 149638 0 28956 0 2589 0 13301 0 14675 0 209159 0 MICHAEL SHEARN CONTRACT RISK ANALYST 156486 0 2314 0 3436 0 4964 0 2084 0 169284 0 SEAN THOMPSON VP BUS. DEV./INT. COO- GENCURE 178435 0 28956 0 2232 0 16084 0 18176 0 243883 0 MARK GAGER VP OF STRATEGY / TECHNOLOGY 188327 0 44802 0 2556 0 18580 0 24109 0 278374 0 PART I, LINE 1A - BENEFITS PROVIDED BY THE ORGANIZATION FINANCIAL SERVICE FEES WERE TREATED AS TAXABLE COMPENSATION TO THE OFFICERS RECEIVING THESE BENEFITS. PART I, LINE 1B - POLICY FOR PAYMENT OR REIMBURSEMENT OF CERTAIN EXPENSES THE ORGANIZATION FOLLOWED THE TERMS OF THE CEO'S EMPLOYMENT CONTRACT IN THE PAYMENT OF FINANCIAL SERVICES. THE BOARD OF DIRECTORS DETERMINED THAT FOR RETENTION PURPOSES IT WAS APPROPRIATE TO PAY FOR THE FINANCIAL SERVICES UTILIZED BY THE CEO. PART I, LINE 4A - SEVERANCE PAYMENT OR CHANGE-OF-CONTROL PAYMENT SEPARATION PAYMENTS SANDRA FAYE MUNOZ $114,218.88 CARMEN DAVILA $50,056.16 PART I, LINE 6A & 6B - COMPENSATION CONTINGENT ON ORGANIZATION'S EARNINGS BIOBRIDGE GLOBAL OFFERS AN INCENTIVE COMPENSATION PLAN THAT IS DEPENDENT ON ACHIEVING VARIOUS MEASURES. ONE OF THE MEASURES IS THAT BIOBRIDGE GLOBAL'S FINANCIAL RESULTS, AS WELL AS BIOBRIDGE GLOBAL'S CONSOLIDATED FINANCIAL RESULTS, MUST MEET OR EXCEED ITS BOARD APPROVED BUDGET. PART I, LINE 1 - ORGANIZATION'S MISSION BIOBRIDGE GLOBAL (BBG) IS ORGANIZED FOR THE EXCLUSIVE PURPOSE OF SUPPORTING, AS THE SOLE MEMBER, SOUTH TEXAS BLOOD & TISSUE CENTER (STBTC), QUALTEX LABORATORIES (QUALTEX), GENCURE, AND THE BLOOD & TISSUE CENTER FOUNDATION (THE FOUNDATION) BY PROVIDING SUPPORT AND ADMINISTRATIVE FUNCTIONS THAT PROMOTE AND SUPPORT THE CHARITABLE MISSION AND PURPOSES OF STBTC, QUALTEX, GENCURE, AND THE FOUNDATION (EACH OF WHICH IS A 501(C)(3) ORGANIZATION). PART VI, LINE 4 - CHANGES TO GOVERNING BOARD SINCE PRIOR FORM 990 BIOBRIDGE GLOBAL'S ORGANIZATIONAL DOCUMENTS WERE AMENDED TO CHANGE THE NUMBER AND TERM OF BOARD MEMBERS AND TO ADD GENCURE AS A SUPPORTED ORGANIZATION. PART VI, LINE 9 - MAILING ADDRESS MARK GAGER - 26219 CUYAHOGA CIRCLE, SAN ANTONIO, TX 78260 PART VI, LINE 11B - PROCESS TO REVIEW THE FORM 990 THE ORGANIZATION ENGAGES AN OUTSIDE ACCOUNTING FIRM TO PREPARE THE FORM 990. ONCE PREPARED, THE RETURN IS REVIEWED BY FINANCIAL MANAGEMENT STAFF PRIOR TO FILING THE RETURN. A COPY OF THE FORM 990 IS PROVIDED TO THE BOARD OF DIRECTORS PRIOR TO FILING. PART VI, LINE 12C - COMPLIANCE WITH CONFLICT OF INTEREST POLICY A COPY OF THE ORGANIZATION'S CONFLICT OF INTEREST POLICY IS PROVIDED ANNUALLY TO ALL OFFICERS AND BOARD OF DIRECTORS. IN ADDITION, QUESTIONNAIRES ARE GIVEN OUT ON AN ANNUAL BASIS TO ALL OFFICERS AND BOARD OF DIRECTORS WHICH COVER BUSINESS AND FAMILY RELATIONSHIPS AND VARIOUS ACTIVITIES THAT HAVE OCCURRED OVER THE COURSE OF THE YEAR. EVERY ATTEMPT IS MADE TO ENSURE THAT ALL FORMS ARE RETURNED. INDIVIDUALS WHO FAIL TO RETURN THE REQUESTED FORMS OR PROVIDE INCOMPLETE INFORMATION ARE CONTACTED BY THE ORGANIZATION. PART VI, LINE 15A - REVIEW OF CEO/TOP MGMT OFFICIAL COMPENSATION UPON HIRE BIOBRIDGE GLOBAL RELIED UPON AN INDEPENDENT COMPENSATION REPORT FROM A NATIONAL COMPENSATION CONSULTING FIRM. THE REPORT STUDIED COMPARABLE ORGANIZATIONS AND PROVIDED DETAILED APPENDICES OF COMPARABLE ORGANIZATIONS' COMPENSATION OF CEO'S IN SUPPORT OF THEIR ANALYSIS. THE INDEPENDENT CONSULTANT'S REPORT IS REVIEWED BY THE COMPENSATION COMMITTEE OF THE ORGANIZATION'S BOARD OF DIRECTORS AND SUBMITTED TO THE BOARD FOR APPROVAL. THE CEO'S COMPENSATION IS EVALUATED ANNUALLY BY THE BOARD'S COMPENSATION COMMITTEE. THE REVIEW IS DOCUMENTED IN THE MEETING MINUTES OF THE BOARD. PART VI, LINE 15B - REVIEW OF OTHER OFFICER'S COMPENSATION BIOBRIDGE GLOBAL UTILIZES AN INDEPENDENT COMPENSATION CONSULTING FIRM, COMPENSATION SURVEYS, COMPENSATION PACKAGES OFFERED BY SIMILAR ORGANIZATIONS IN OUR PEER GROUP, AND/OR MARKET COMPETITIVE ANALYSES. Part VI, Line 16b - POLICY FOR ARRANGEMENTS WITH TAXABLE ENTITIES The organization has not established written procedures but is committed to ensuring that any arrangements entered into safeguard the organization's exempt status. Blood Centers of America is made up of members, all of whom are exempt organizations within the meaning of Section 501(c)(3) of the Internal Revenue Code of 1986, as amended. PART VI, LINE 19 - HOW DOCUMENTS ARE MADE AVAILABLE TO PUBLIC UPON REQUEST. Part VI, Line 1B - VOTING MEMBERS OF THE BOARD NOT INDEPENDENT ONE MEMBER OF THE BOARD OF DIRECTORS IS NOT DEEMED INDEPENDENT BECAUSE SHE RECEIVED COMPENSATION AS AN OFFICER OF THE ORGANIZATION. TWO OFFICERS OF THE BOARD OF DIRECTORS ARE NOT DEEMED INDEPENDENT DUE TO THE RECEIPT OF PAYMENTS FOR SERVICES RENDERED TO entities related to these officers. ALL TRANSACTIONS WERE CONDUCTED AT ARMS-LENGTH. PART VIII, LINE 2A - FORM 990 STATEMENT OF REVENUE BIOBRIDGE Global's REVENUES ARE DERIVED FROM THE SUPPORT AND ADMINISTRATIVE SERVICES PROVIDED TO ITS RELATED ORGANIZATIONS. SOUTH TEXAS BLOOD & TISSUE CENTER 6211 IH 10 WEST SAN ANTONIO TX 78201 237379332 BLOOD BANK TX 501(C)(3) 9 SEE PART VII true THE BLOOD & TISSUE CENTER FOUNDATION 6211 IH 10 WEST SAN ANTONIO TX 78201 431970952 SUPPORT ORG. TX 501(C)(3) 11A SEE PART VII true QUALTEX LABORATORIES 6211 IH 10 WEST SAN ANTONIO TX 78201 208429619 TEST PUB SFTY AZ 501(C)(3) 10 SEE PART VII true GENCURE 6211 IH 10 WEST SAN ANTONIO TX 78201 462216869 CEL & TIS SVC TX 501(C)(3) 9 SEE PART VII true false false false false false false false false false false true false false true true true true false false SOUTH TEXAS BLOOD & TISSUE CENTER K 517029 BOOK COST QUALTEX LABORATORIES N 2521989 BOOK COST SOUTH TEXAS BLOOD & TISSUE CENTER N 3207842 BOOK COST QUALTEX LABORATORIES O 4735024 BOOK COST SOUTH TEXAS BLOOD & TISSUE CENTER O 6022709 BOOK COST SOUTH TEXAS BLOOD & TISSUE CENTER Q 3498769 BOOK COST QUALTEX LABORATORIES Q 4452167 BOOK COST SOUTH TEXAS BLOOD & TISSUE CENTER P 6317762 BOOK COST QUALTEX LABORATORIES P 634007 BOOK COST THE BLOOD & TISSUE CENTER FOUNDATION Q 267082 BOOK COST GENCURE Q 1169153 BOOK COST GENCURE N 1117013 BOOK COST GENCURE O 2097186 BOOK COST SCHEDULE R, PART II, COLUMN F THE ORGANIZATIONS SPECIFIED ARE ALL CONTROLLED BY BIOBRIDGE GLOBAL.